Parkinson's disease Symptoms Before and After Levodopa-Carbidopa Intestinal Gel: a Subanalysis From the COSMOS Study

被引：0
|
作者：
Fasano, A. [1 ]
Toomsoo, T. [2 ]
Hassin-Baer, S.
Van Kesteren, M.
Parra, J. [3 ]
Femia, S.
Chico, S.
Alobaidi, A.
Szasz, J.
机构：
[1] Div Neurol, Toronto, ON, Canada
[2] Dept Neurol, Tallinn, Estonia
[3] AbbVie Inc, N Chicago, IL USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
OPR-150
引用
收藏
页码：164 / 164
页数：1
相关论文
共 50 条
  • [21] Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel
    Solla, Paolo
    Cannas, Antonino
    Marrosu, Maria Giovanna
    Marrosu, Francesco
    PARKINSONISM & RELATED DISORDERS, 2015, 21 (11) : 1383 - 1384
  • [22] Utilization of Monotherapy and Combination Therapies in Advanced Parkinson Disease Patients During Levodopa-Carbidopa Intestinal Gel Treatment from the COSMOS Study
    Fasano, A.
    Parra, J. C.
    Gurevich, T.
    Jech, R.
    Kovacs, N.
    Svenningsson, P.
    Szasz, J.
    Bergmann, L.
    Johnson, A.
    Sanchez-Solino, O.
    Tang, Z.
    Vela-Desojo, L.
    MOVEMENT DISORDERS, 2019, 34 : S39 - S40
  • [23] Direct Endoscopic Jejunostomy for the Administration of Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
    Vinh-an Phan
    Schoeman, Mark
    Kimber, Thomas
    GASTROINTESTINAL ENDOSCOPY, 2015, 81 (05) : AB307 - AB308
  • [24] Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients
    Antonini, Angelo
    Fung, Victor S. C.
    Boyd, James T.
    Slevin, John T.
    Hall, Coleen
    Chatamra, Krai
    Eaton, Susan
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2016, 31 (04) : 530 - 537
  • [25] Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
    Francesc Valldeoriola
    María José Catalán
    Francisco Escamilla-Sevilla
    Eric Freire
    Jesús Olivares
    Esther Cubo
    Diego Santos García
    Matilde Calopa
    Pablo Martínez-Martín
    Juan Carlos Parra
    Gloria Arroyo
    José Matías Arbelo
    npj Parkinson's Disease, 7
  • [26] Weight, BMI, and Dyskinesia in Patients With Parkinson's Disease on Levodopa-Carbidopa Intestinal Gel
    Pontieri, F.
    Bourgeois, P.
    Chaudhuri, K.
    Siddiqui, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Simu, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 230 - 230
  • [27] Implementing Levodopa-Carbidopa Intestinal Gel for Parkinson Disease: Insights from US Practitioners
    Burack, Michelle
    Aldred, Jason
    Zadikoff, Cindy
    Vanagunas, Arvydas
    Klos, Kevin
    Bilir, Bahri
    Fernandez, Hubert H.
    Standaert, David G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (04): : 383 - 393
  • [28] Levodopa-Carbidopa Intestinal Gel Improves Long-term Parkinson's Disease Symptoms: Final Analysis of the DUOGLOBE Study
    Chaudhuri, K.
    Kovacs, N.
    Pontieri, F.
    Aldred, J.
    Bourgeois, P.
    Davis, T.
    Cubo, E.
    Anca-Herschkovitsch, M.
    Iansek, R.
    Siddiqui, M.
    Simu, M.
    Bergmann, L.
    Kukreja, P.
    Ladhani, O.
    Jia, J.
    Standaert, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 449 - 450
  • [29] Efficacy of Levodopa-Carbidopa Intestinal Gel Versus Oral Levodopa-Carbidopa in Advanced Parkinson's: Sensitivity and Responder Analyses
    Boyd, James T.
    Fernandez, Hubert H.
    Slevin, John T.
    Espay, Alberto J.
    Standaert, David G.
    Pritchett, Yili
    Zhang, Wuyan
    Chatamra, Krai
    Widnell, Katherine L.
    Benesh, Janet
    ANNALS OF NEUROLOGY, 2013, 74 : S44 - S44
  • [30] Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations
    R. Balestrino
    T. Martone
    M. Toffoli
    E. Montanaro
    M. Fabbri
    C. A. Artusi
    A. Romagnolo
    M. Zibetti
    M. Rizzone
    S. Goldwurm
    L. Lopiano
    A. H. V. Schapira
    Neurological Sciences, 2024, 45 : 1489 - 1497
12345